MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 125 percent decrease over losses of $(0.04) per share from the
U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session.
MiMedx Group, Inc. (NASDAQ:MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that the Japanese Ministry of Health, Labour and Welfare (JMHLW)
MiMedx Group (NASDAQ:MDXG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
MiMedx Group missed estimated earnings by 83.33%, reporting an EPS of $-0.11 versus an estimate of $-0.06.